AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Aya Ziad Bakkar

Examiner Aya Ziad Bakkar appears to be about average relative to their peer examiners. Their lifetime grant ratio is 47.2%, they average 2.52 office actions per granted patent, and their rejection profile is dominated by ยง103.

Difficulty vs AU About Average
Difficulty vs Group About Average
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.52
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
7 years (2020-2026)
Phone
(313) 446-6659
Predicted Supervisor
N/A
Supervisor Phone
N/A
Tech Center
3700 - Mechanical Engineering, Manufacturing and Products
Group
3790 - Medical Instruments, Diagnostic Equipment, and Treatment Devices

Metrics

Applications Evaluated
218
Granted Applications
103
Non-Granted Applications
115
Avg OA / Grant
2.52
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
3792 , 3796
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 47.2% 2.52
Art Unit 19 17.8% 2.38
Group 327 40.3% 2.25
Tech Center 2,632 49.9% 2.01
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2020 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2020; examiner may not yet have been active in the available dataset.
2020 2 1 50.0%
2021 33 23 69.7%
2022 42 21 50.0%
2023 33 24 72.7%
2024 51 27 52.9%
2025 39 7 17.9%
2026 18 0 0.0%

103 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 216 0.5% 6.9% 78.7% 10.2%
2 120 2.5% 7.5% 87.5% 1.7%
3 75 0.0% 4.0% 92.0% 2.7%
4 44 0.0% 4.5% 90.9% 4.5%
5 20 0.0% 5.0% 95.0% 0.0%
6 13 0.0% 0.0% 100.0% 0.0%
7 5 0.0% 0.0% 80.0% 0.0%
8 2 0.0% 0.0% 100.0% 0.0%
9 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2020
1.0%
2021
1.1%
2022
0.0%
2023
1.0%
2024
1.4%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.